Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J. Nastoupil, Frederick L. Locke, Michael D. Jain et al.|Journal of Clinical Oncology|2020Cited by 782
Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled TrialTze Pin Ng, Keng Bee Yap, Liang Feng et al.|The American Journal of Medicine|2015Cited by 740
Cognitive Frailty and Adverse Health Outcomes: Findings From the Singapore Longitudinal Ageing Studies (SLAS)Liang Feng, Tze Pin Ng, Ma Shwe Zin Nyunt et al.|Journal of the American Medical Directors Association|2016Cited by 292
SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosisLei Feng, Baosheng Li|Journal of Translational Medicine|2021Cited by 268
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trialNathan Fowler, Sattva S. Neelapu, Linda Claret et al.|The Lancet Oncology|2014Cited by 263